CGC
Canopy Growth Corp
NASDAQ: CGC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.11
+1.83% today
Updated 2026-04-30
Market cap
$619.73M
P/E ratio
—
P/S ratio
2.23x
EPS (TTM)
$-1.36
Dividend yield
—
52W range
$1 – $2
Volume
11.0M
Canopy Growth Corp (CGC) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6997.00 | $-28411.00 | $-18651.00 | $-36998.00 | $-1.38M | $-9.75M | $-9.75M | $-12.45M | $-27.09M | $-81.51M | $-535.03M | $-772.63M | $-465.73M | $-545.81M | $-557.55M | $-281.95M | $-165.75M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $1.05M | $11.22M | $11.97M | $10.71M | $29.53M | $178.09M | $718.82M | $721.90M | $174.14M | $48.11M | $10.45M | $4.00M | $11.28M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $12600.00 | — | — | $25410.00 | $153764.00 | — | $2.24M | $3.68M | $10.04M | $51.18M | $278.23M | $320.28M | $91.15M | $46.69M | $25.32M | $14.18M | $-4.21M |
| Free cash flow | $-6997.00 | $-28411.00 | $-18651.00 | $-36998.00 | $-2.43M | $-20.97M | $-21.71M | $-23.16M | $-56.63M | $-259.60M | $-1.25B | $-1.49B | $-639.87M | $-593.92M | $-568.00M | $-285.95M | $-177.03M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — |